This finding not only contributes to our understanding of MAP7's functional repertoire but also highlights its potential as a pivotal factor in cancer drug resistance, opening avenues for targeted therapeutic strategies against ovarian cancer and possibly other malignancies exhibiting chemoresistance. This evidence concerns the gene MAP7 and cancer.